Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT02148367
What this trial is testing

Effect of Recombinant Erythropoietin on Numbers of Circulating Endothelial Progenitor Cells in Subacute TBI

Who this might be right for
Traumatic Brain Injury
Uniformed Services University of the Health Sciences
Testing effectiveness (Phase 2)Study completedNCT00094107
What this trial is testing

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Neoplasms
Pfizer 32
Testing effectiveness (Phase 2)Study completedNCT01705184
What this trial is testing

Re-introduction of Pemetrexed and Cisplatin With Prolonged Angiogenic Blocking by Bevacizumab in Advanced Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer MetastaticNonsquamous Nonsmall Cell Neoplasm of Lung
Intergroupe Francophone de Cancerologie Thoracique 120
Very early researchStudy completedNCT01738815
What this trial is testing

Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer

Who this might be right for
HematuriaBladder Cancer
State University of New York - Upstate Medical University 43
Not applicableStudy completedNCT01525472
What this trial is testing

Accelerated Aging of the Cells of Visceral Adipose Tissue in Morbid Obese Subjects

Who this might be right for
Morbid Obesity
Institut National de la Santé Et de la Recherche Médicale, France 186
Testing effectiveness (Phase 2)UnknownNCT03505346
What this trial is testing

68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Angiogenesis in Ischemic Heart Disease

Who this might be right for
Chronic Ischemic Heart Disease
Rigshospitalet, Denmark 42
Testing effectiveness (Phase 2)Study completedNCT00083408
What this trial is testing

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Who this might be right for
Multiple Myeloma
University of Arkansas 20
Testing effectiveness (Phase 2)Looking for participantsNCT07014137
What this trial is testing

A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas

Who this might be right for
Sarcoma
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Study completedNCT03126331
What this trial is testing

Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab

Who this might be right for
Metastatic Renal Cell Carcinoma
Case Comprehensive Cancer Center 26
Not applicableLooking for participantsNCT04464122
What this trial is testing

Rediscovering Biomarkers for the Diagnosis and Early Treatment Response in NEN (REBORN)

Who this might be right for
Neuroendocrine TumorsNeuroendocrine NeoplasmNeuroendocrine Tumor Grade 1+2 more
University of Roma La Sapienza 60
Early research (Phase 1)Study completedNCT00005822
What this trial is testing

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00304525
What this trial is testing

Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Novartis Pharmaceuticals 104
Testing effectiveness (Phase 2)Study completedNCT00842335
What this trial is testing

A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Jubilant Innovation Ltd. 18
Large-scale testing (Phase 3)Looking for participantsNCT07472140
What this trial is testing

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancersPrimary Peritoneal Cancer
N.N. Alexandrov National Cancer Centre 120
Not applicableStudy completedNCT06993740
What this trial is testing

Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient

Who this might be right for
Flap MonitoringInflammationThrombosis+8 more
Dharmais National Cancer Center Hospital 60
Post-approval studies (Phase 4)Study completedNCT01922154
What this trial is testing

Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma

Who this might be right for
Glaucoma, Neovascular
Siriraj Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01079780
What this trial is testing

Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group 136
Testing effectiveness (Phase 2)Looking for participantsNCT06482801
What this trial is testing

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Who this might be right for
Liver CancerAntibody
Second Affiliated Hospital of Guangzhou Medical University 90
Not applicableStudy completedNCT02692079
What this trial is testing

The Effectiveness of Titanium-Prepared Platelet-Rich Fibrin on Angiogenic Biomarkers in Gingival Crevicular Fluid

Who this might be right for
Chronic PeriodontitisIntrabony Periodontal Defect
Kırıkkale University 25
Large-scale testing (Phase 3)Ended earlyNCT04113187
What this trial is testing

Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaOsler Weber Rendu Disease
University Hospital, Bordeaux 15
Next Page